Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matt Shirley

Showing results (1-10 of 84) with videos related to

Pageof 9
Sort By:
Drugs|March 17, 2025
Stapokibart: First ApprovalMatt Shirley
Drugs|December 4, 2018
Dacomitinib: First Global ApprovalMatt Shirley
Drugs|April 4, 2019
Correction to: Amikacin Liposome Inhalation Suspension: A Review in Mycobacterium avium Complex Lung DiseaseMatt Shirley
Drugs|April 20, 2018
Ceftazidime-Avibactam: A Review in the Treatment of Serious Gram-Negative Bacterial InfectionsMatt Shirley
Drugs|December 21, 2016
Olaratumab: First Global ApprovalMatt Shirley
Drugs|December 6, 2021
Correction to: Maralixibat: First ApprovalMatt Shirley
Drugs|November 23, 2021
Maralixibat: First ApprovalMatt Shirley
Targeted Oncology|December 24, 2021
Correction to: Bruton Tyrosine Kinase Inhibitors in B-Cell Malignancies: Their Use and Differential FeaturesMatt Shirley
Drugs|September 24, 2021
Correction to: Netupitant/Palonosetron: A Review in Chemotherapy-Induced Nausea and VomitingMatt Shirley
Drugs|November 19, 2025
Aztreonam-Avibactam: A Review in the Treatment of Serious Bacterial Infections Caused by Aerobic Gram-Negative OrganismsMatt Shirley
Pageof 9

Showing results (1-10 of 84) with videos related to

Sort By:
Pageof 9
Drugs|March 17, 2025
Stapokibart: First ApprovalMatt Shirley
Drugs|December 4, 2018
Dacomitinib: First Global ApprovalMatt Shirley
Drugs|April 4, 2019
Correction to: Amikacin Liposome Inhalation Suspension: A Review in Mycobacterium avium Complex Lung DiseaseMatt Shirley
Drugs|April 20, 2018
Ceftazidime-Avibactam: A Review in the Treatment of Serious Gram-Negative Bacterial InfectionsMatt Shirley
Drugs|December 21, 2016
Olaratumab: First Global ApprovalMatt Shirley
Drugs|December 6, 2021
Correction to: Maralixibat: First ApprovalMatt Shirley
Drugs|November 23, 2021
Maralixibat: First ApprovalMatt Shirley
Targeted Oncology|December 24, 2021
Correction to: Bruton Tyrosine Kinase Inhibitors in B-Cell Malignancies: Their Use and Differential FeaturesMatt Shirley
Drugs|September 24, 2021
Correction to: Netupitant/Palonosetron: A Review in Chemotherapy-Induced Nausea and VomitingMatt Shirley
Drugs|November 19, 2025
Aztreonam-Avibactam: A Review in the Treatment of Serious Bacterial Infections Caused by Aerobic Gram-Negative OrganismsMatt Shirley
Pageof 9